Published by Global Banking & Finance Review®
Posted on February 6, 2026
2 min readLast updated: February 6, 2026
Add as preferred source on GoogleNovo Nordisk shares rose 4.7% after the FDA targeted illegal drug copies, following a price drop due to cheaper Wegovy alternatives.
By Jacob Gronholt-Pedersen
COPENHAGEN, Feb 6 (Reuters) - Shares in Danish drugmaker Novo Nordisk gained 4.7% in early trading on Friday, recovering some of the previous two sessions' steep losses, after the U.S. Food and Drug Administration (FDA) pledged to address mass-marketing of unapproved drugs.
The stock plunged nearly 8% on Thursday after telehealth company Hims and Hers Health launched a significantly cheaper $49 compounded version of Novo Nordisk's FDA-approved Wegovy weight-loss pill.
"FDA will take swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products," FDA Commissioner Marty Makary said on X without naming any companies.
"The FDA cannot verify the quality, safety or effectiveness of non-approved drugs," he said.
Novo warned on Wednesday of unprecedented price pressure on its weight-loss medicines and dropped its full-year forecast, triggering a 17% slump in its share price.
Novo's shares are near their lowest since Wegovy was introduced in June 2021.
By 0848 GMT the shares were up 4.9% at 294.50 Danish crowns ($46.50).
($1 = 6.3327 Danish crowns)
(Reporting by Jacob Gronholt-PedersenEditing by David Goodman)
Stock recovery refers to the process of a company's stock price rebounding after a decline, often due to positive news or market conditions that restore investor confidence.
Weight-loss medications are drugs prescribed to assist individuals in losing weight, often by suppressing appetite or increasing feelings of fullness.
Market reaction is the response of investors and traders to news or events that affect a company's stock price, leading to buying or selling activities.
Price pressure refers to the influence that competition or market conditions have on the pricing of products, often leading to lower prices for consumers.
Explore more articles in the Finance category
